These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4730977)

  • 21. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

  • 22. The need for new antituberculous drugs.
    Dahlström G
    Scand J Respir Dis Suppl; 1969; 69():11-3. PubMed ID: 4906370
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intermittent intravenous chemotherapy of patients with newly detected pulmonary tuberculosis].
    Serebrova NI; Kononenko VG; Sharapova LN; Kiskevich MI; Savelova SA
    Probl Tuberk; 1975; (3):51-4. PubMed ID: 1135203
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histamine-binding capacity of blood serum in patients with pulmonary tuberculosis.
    Sillastu H; Hering L
    Ann Med Intern Fenn; 1967; 56(1):15-8. PubMed ID: 6040354
    [No Abstract]   [Full Text] [Related]  

  • 26. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN
    Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
    [No Abstract]   [Full Text] [Related]  

  • 27. [Continuous and intermittent administration of standard drugs with supervised regimen in previously untreated pulmonary tuberculosis. II. Obstacles encountered during treatment, delayed results, therapy acceptance, organizational and economic aspects].
    Zierski M; Bek E; Zachara A; Dabrowska Z
    Gruzlica; 1973 Feb; 41(2):157-67. PubMed ID: 4695787
    [No Abstract]   [Full Text] [Related]  

  • 28. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 29. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs in the treatment of tuberculosis--1969.
    Beacham EG
    Johns Hopkins Med J; 1969 Nov; 125(5):286-90. PubMed ID: 5366128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term results of chemotherapy of newly detected patients with destructive pulmonary tuberculosis].
    Roslik SM; Pashkov IuN; Matveeva SL; Iushchenko LP; Gerasimova TG; Liudvichek IA; Iakovleva LM; Stepanenko AL; Pankova LI
    Probl Tuberk; 1991; (2):33-6. PubMed ID: 2034639
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of pulmonary tuberculosis by the intravenous infusion of tuberculostatic preparations].
    Volynskiĭ IP
    Voen Med Zh; 1974 Feb; (2):69-70. PubMed ID: 4456792
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs].
    Mysakowska H; Pietroń E; Sikora-Rózyńska M; Smaga M; Litwin B; Rybicka-Stryjecka Z
    Pol Tyg Lek; 1965 May; 20(19):686-8. PubMed ID: 5844021
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
    Henneghien C; Ballez C; Horvath K; el-Fassi M
    Acta Tuberc Pneumol Belg; 1969; 60(6):821-32. PubMed ID: 5397018
    [No Abstract]   [Full Text] [Related]  

  • 35. [On some causes of failure in the treatment of pulmonary tuberculosis].
    Vasić D
    Tuberkuloza; 1965; 17(3):221-32. PubMed ID: 5844893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Short- and long-term results of 6-month chemotherapy in patients with newly detected pulmonary tuberculosis].
    Gamperis Iu; Gaĭdamonene D; Dimbelene M
    Probl Tuberk; 1993; (4):58. PubMed ID: 8127846
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intermittent chemotherapy of newly detected pulmonary tuberculosis].
    Tabidze ShA; Vashakidze LM
    Probl Tuberk; 1982 Nov; (11):36-9. PubMed ID: 7156102
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M
    Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.